EZH2 and thyroid gland carcinoma: Recent study found that PVT1 contributed to tumorigenesis of thyroid cancer through recruiting enhancer of zeste homolog 2 (EZH2) [8], and promoting glioma vascular endothelial cell proliferation, migration, and angiogenesis by targetting miR-186 [9].